Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for HR+ HER2- MBC
moderators
Posts: 9,710
May 31, 2025
After two years of follow-up, the new treatment improved survival and quality of life. Read more…
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.